RE: Full Government Plan22 Feb 2021 18:36
Some Vaccine info from the document
58. Early data for the AstraZeneca vaccine suggests a good level of protection after one dose but, as deployment of this vaccine only started in January 2021, at this stage the size of the effect is less certain.
59. Third, in older people (aged 80 and over) who do develop COVID-19 infection, those who are vaccinated, most of whom have so far had one dose, have a much lower chance of hospitalisation (about 40% lower) and death (around 56% lower) than those who are unvaccinated.
Preparing for revaccination
65. It is not currently known for how long people who receive a COVID-19 vaccine will be protected. This is because, as is the case with many vaccines, the protection they confer may weaken over time. It is also possible that new variants of the virus may emerge against which current vaccines are less effective. As well as working closely with manufacturers, Government scientists are seeking to better understand the impact of some Variants of Concern on the vaccines currently in deployment.
66. To ensure the country is prepared for these scenarios and while further evidence is gathered, the Government is planning for a revaccination campaign, which is likely to run later this year in autumn or winter. Any revaccination is likely to consist of a single ‘booster’ dose of a COVID-19 vaccine: the ideal booster may be a new vaccine specifically designed against a variant form of the virus. Over the longer term, revaccination is likely to become a regular part of managing COVID-19.
***
Pretty interesting AZN vaccine in over 80's gives a 40% reduction in hospitalisation and 56% reduction in death according to this document. Those numbers are not as high as MSM were reporting over last week.
Planning regular booster shots of vaccine too suggests Covid-19 is endemic.
Sign In
Follow the stocks
